Oxytocin signaling in the posterior hypothalamus prevents hyperphagic obesity in mice.
Kengo InadaKazoku TsujimotoMasahide YoshidaKatsuhiko NishimoriKazunari MiyamichiPublished in: eLife (2022)
Decades of studies have revealed molecular and neural circuit bases for body weight homeostasis. Neural hormone oxytocin (Oxt) has received attention in this context because it is produced by neurons in the paraventricular hypothalamic nucleus (PVH), a known output center of hypothalamic regulation of appetite. Oxt has an anorexigenic effect, as shown in human studies, and can mediate satiety signals in rodents. However, the function of Oxt signaling in the physiological regulation of appetite has remained in question, because whole-body knockout (KO) of Oxt or Oxt receptor ( Oxtr ) has little effect on food intake. We herein show that acute conditional KO (cKO) of Oxt selectively in the adult PVH, but not in the supraoptic nucleus, markedly increases body weight and food intake, with an elevated level of plasma triglyceride and leptin. Intraperitoneal administration of Oxt rescues the hyperphagic phenotype of the PVH Oxt cKO model. Furthermore, we show that cKO of Oxtr selectively in the posterior hypothalamic regions, especially the arcuate hypothalamic nucleus, a primary center for appetite regulations, phenocopies hyperphagic obesity. Collectively, these data reveal that Oxt signaling in the arcuate nucleus suppresses excessive food intake.
Keyphrases
- body weight
- weight loss
- high fat diet induced
- type diabetes
- insulin resistance
- metabolic syndrome
- weight gain
- endothelial cells
- single cell
- signaling pathway
- mouse model
- machine learning
- intensive care unit
- genome wide
- dna methylation
- electronic health record
- spinal cord injury
- skeletal muscle
- working memory
- spinal cord
- artificial intelligence
- body mass index
- physical activity
- data analysis
- acute respiratory distress syndrome
- respiratory failure
- binding protein
- induced pluripotent stem cells
- drug induced
- childhood cancer